Scholarlink

<p>Asthma control remains suboptimal worldwide, often due to modifiable factors such as incorrect inhaler technique and reliever overuse. Community pharmacists (CPs) are well-positioned to address these gaps through structured patient education. A point prevalence evaluation was conducted in 1247 patients across 127 community pharmacies (11.1% of all pharmacies) in North Macedonia (Dec 2023–Sep 2024). Asthma control was assessed using the Asthma Control Test (ACT), while Asthma Slide Rule (ASR) was used to evaluate short-acting beta-agonists (SABAs) use. Inhaler technique was assessed using device-specific checklists. CPs provided comprehensive care, including adherence support, lifestyle counselling, and monitoring. Poor inhaler technique strongly predicted poor asthma control (ACT: OR = 5.98; ASR: OR = 6.43). Among 127 patients followed, correct technique improved from 71.7% at baseline to 88.8% at the second visit, and among patients who attended all three visits, accuracy increased from ∼63% at the first visit to∼89% at the second and 98.2% at the third (56 patients). By the third visit, the association between technique and control diminished, reflecting the success of comprehensive pharmaceutical care. These results highlight the critical, multifaceted role of CPs in improving asthma outcomes and support the integration of CP-led comprehensive pharmaceutical care for asthma into national management strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Educating the patient, controlling the disease: a point prevalence evaluation of structured pharmaceutical asthma care in real world settings

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月16日

查看全文
  • Maja Simonoska Crcarevska,
  • Zorica Naumovska,
  • Beti Zafirova Ivanovska,
  • Biljana Bozhinovska,
  • Joana Andonoska,
  • Sashka Janevska,
  • Siân Williams,
  • Jaime Correia-de-Sousa,
  • Katarina Stavriкј

摘要

Asthma control remains suboptimal worldwide, often due to modifiable factors such as incorrect inhaler technique and reliever overuse. Community pharmacists (CPs) are well-positioned to address these gaps through structured patient education. A point prevalence evaluation was conducted in 1247 patients across 127 community pharmacies (11.1% of all pharmacies) in North Macedonia (Dec 2023–Sep 2024). Asthma control was assessed using the Asthma Control Test (ACT), while Asthma Slide Rule (ASR) was used to evaluate short-acting beta-agonists (SABAs) use. Inhaler technique was assessed using device-specific checklists. CPs provided comprehensive care, including adherence support, lifestyle counselling, and monitoring. Poor inhaler technique strongly predicted poor asthma control (ACT: OR = 5.98; ASR: OR = 6.43). Among 127 patients followed, correct technique improved from 71.7% at baseline to 88.8% at the second visit, and among patients who attended all three visits, accuracy increased from ∼63% at the first visit to∼89% at the second and 98.2% at the third (56 patients). By the third visit, the association between technique and control diminished, reflecting the success of comprehensive pharmaceutical care. These results highlight the critical, multifaceted role of CPs in improving asthma outcomes and support the integration of CP-led comprehensive pharmaceutical care for asthma into national management strategies.